Posts

Showing posts from September, 2018

HIV Diagnosis Market value set to reach industry expectations, 2023

The diagnosis of HIV detects the presence of the human immunodeficiency virus (HIV), which causes the acquired immunodeficiency syndrome (AIDS). This is done by carrying out certain tests in serum, saliva, or urine samples. These tests may detect antibodies, antigens, or RNA. The increasing awareness about HIV, confidentiality of the test, and appropriate counseling increases the demand for this process. Get Access to TOC / Sample Report @  https://www.alliedmarketresearch.com/request-toc-and-sample/2815 The major factors that contribute to the growth of the global HIV diagnosis market includes the increasing prevalence of HIV/AIDS worldwide, increasing number of blood transfusions & blood donations that cause infections, which lead to HIV, benefits offered by point-of-care instruments & kits, technological advancements, and increasing government initiatives. However, high costs of Nucleic Acid Testing (NAT) and lack of mandates for NAT in developing countries are...

Clinical Trial Management (CTM) Market value set to reach $1,371 Mn by 2023

Image
According to a new report published by Allied Market Research, titled,  Clinical Trial Management Market by Delivery Mode, Product, Component, End Users, and Region: Global Opportunity Analysis and Industry Forecast, 2017-2023,  the global clinical trial management market accounted for $570 million in 2016 , and is estimated to reach $1,371 million by 2023 , registering a CAGR of 13.4% from 2017 to 2023 . North America is the highest contributor in the clinical trial management market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period. The Clinical Trial Management System (CTMS) helps in the maintenance of the broad and highly complex data obtained from clinical trials. The system also tracks clinical trials that occur in different parts of the word, and data can be routinely analyzed through multiple regression, simulation, and other models. In addition, clinical trial management systems can help optimize time manag...

Medical Marijuana Market determined to grow faster by 2023

Marijuana refers to the dried leaves, flowers, stems, and seeds from the hemp plantCannabis sativa. There are 2 main active chemicals in Marijuanacannabidiol (CBD) and tetrahydocannabinol (THC), which impact the brain and relieve the pain, respectively. Marijuana provides pain relief in conditions such as fibromyalgia, grand mal seizures, and other medical conditions. Similarly, it reduces symptoms of many serious medical conditions such as AIDS, cancer, and glaucoma. Increased disease prevalence and increased demand for palliative care for diseases such as cancer, AIDS, seizures and other diseases are driving the medical marijuana market for medical marijuana. In 2016, marijuana was medically available in Colombia, Macedonia, Israel, Germany, Australia and other countries. Thus, as the number of countries that legitimize the use of medical marijuana increases, it is expected to stimulate market growth during the forecast period. In addition, the increase in the number of strict ...

Spinal Implants and Devices Market Expected to Reach $13,384 Mn by 2022

The Global  Spinal Implants and Devices Market  was worth $9,741 million in 2015, and is estimated to reach $13,384 million by 2022, growing at a CAGR of 4.6% during the study period. Spinal implants and devices are used to treat spinal deformities such as spinal stenosis and isthmic spondylolisthesis. Increase in geriatric population, rise in adoption of minimal invasive surgery techniques, and upsurge in incidence rate of spinal disorders are expected to drive the market growth. Moreover, technological advancements in spinal fusion implants fuel this growth. However, unfavorable reimbursement scenario and stringent regulatory approval procedures are expected to impede the market growth. Get Free Access to Sample Report @  https://www.alliedmarketresearch.com/request-sample/1620 Spinal stenosis is the most common problem in men and women over 50 years of age. With age, changes occur in the structure of the spine, such as the band of the tissue that supports the sp...

Epigenetics Market : Industry to Witness a Rise by year 2023

Global  Epigenetics Market   was valued at $555 million in 2016, and is estimated to reach at $1,321 million by 2023, registering a CAGR of 13.1% from 2017 to 2023. Epigenetics is an extension of genetics and developmental biology, which involves study of cellular and physiological trait variations initiated by external or environmental stimuli. Epigenetics deals with changes in gene expression caused by certain base pairs in DNA & RNA, which are “turned off” or “turned on”, through chemical reactions contrary to being affected by changes in the nucleotide sequence. Epigenetic alterations result into change in phenotype, with the genotype of the organism being constant. Epigenetics changes are influenced by different factors, such as age, surrounding environment, lifestyle, disease state, and others. DNA methylation and histone modification for instance are epigenetic processes wherein the alteration in gene expression is observed without the change in the DNA sequence....